Click image to enlarge
The Mouse ProInflammatory 7-Plex Tissue Culture Kit provides assay-specific components for the simultaneous quantitative determination of both natural and recombinant mouse IFN-γ, IL-1β, IL-6, IL-10, IL-12p70, KC/GRO/CINC, and TNF-α in tissue culture supernatant.
-
-
Specifications
-
-
Documentation
-
References
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
Analyte(s)
|
|
IFN-γ, IL-1β, IL-6, IL-10, IL-12p70, KC/GRO, TNF-α
|
|
Species
|
|
Mouse
|
|
Plate Type
|
|
96-well
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
Capture Antibody
|
|
IFN-γ: Rat Monoclonal IL-1β: Mouse Monoclonal IL-6: Rat Monoclonal KC/GRO: Rat Monoclonal IL-10: Rat Monoclonal IL-12p70: Rat Monoclonal TNF-α: Rat Monoclonal
|
|
Detection Antibody
|
|
IFN-γ: Rat Monoclonal IL-1β: Goat Polyclonal IL-6: Goat Polyclonal KC/GRO: Goat Polyclonal IL-10: Goat Polyclonal IL-12p70: Goat Polyclonal TNF-α: Rat Monoclonal
|
|
LLOD (Sensitivity)
|
|
IFN-γ: 0.20 pg/mL IL-1β: 0.44 pg/mL IL-6: 2.6 pg/mL KC/GRO: 1.3 pg/mL IL-10: 6.4 pg/mL IL-12p70: 10 pg/mL TNF-α: 1.0 pg/mL
|
|
Dynamic Range
|
|
IFN-γ: 0.20-10000 pg/mL IL-1β: 0.44-10000 pg/mL IL-6: 2.6-10000 pg/mL KC/GRO: 1.3-10000 pg/mL IL-10: 6.4-10000 pg/mL IL-12p70: 10-10000 pg/mL TNF-α: 1.0-10000 pg/mL
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
Storage Condition
|
|
Multi-Component
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
|
|
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
View All
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters